Management of Sickle Cell DiseaseBarbara P. Yawn, Joylene John‐Sowah, George R. Buchanan et al.|JAMA|2014Cited by 1.6k
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitorsScott Kaatz, Jack Ansell, Peter A. Kouides et al.|American Journal of Hematology|2012Cited by 366
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel MembersBarbara P. Yawn, Joylene John‐Sowah, George R. Buchanan et al.|Survey of Anesthesiology|2015Cited by 270
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testingSaskia Middeldorp, Alfonso Iorio, Lisa Baumann Kreuziger et al.|Blood Advances|2023Cited by 236
Knowledge gaps in reproductive and sexual health in girls and women with sickle cell diseaseLydia H. Pecker, Kim Smith‐Whitley, Deva Sharma et al.|British Journal of Haematology|2021Cited by 49